These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 9827816

  • 21. N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin.
    Rio B, Bauduer F, Arrago JP, Zittoun R.
    Bone Marrow Transplant; 1993 Jun; 11(6):471-2. PubMed ID: 8334428
    [Abstract] [Full Text] [Related]

  • 22. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation.
    Blostein MD, Paltiel OB, Thibault A, Rybka WB.
    Bone Marrow Transplant; 1992 Nov; 10(5):439-43. PubMed ID: 1464007
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. von Willebrand factor as a marker of endothelial cell activation following BMT.
    Collins PW, Gutteridge CN, O'Driscoll A, Blair S, Jones L, Aitchison R, Kelsey SM, Chopra R, Goldstone A, Newland AC.
    Bone Marrow Transplant; 1992 Dec; 10(6):499-506. PubMed ID: 1490199
    [Abstract] [Full Text] [Related]

  • 25. Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients.
    Essell JH, Thompson JM, Harman GS, Halvorson RD, Snyder MJ, Callander NS, Clement DJ.
    Bone Marrow Transplant; 1992 Oct; 10(4):367-72. PubMed ID: 1422493
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.
    Pihusch M, Wegner H, Goehring P, Salat C, Pihusch V, Andreesen R, Kolb HJ, Holler E, Pihusch R.
    Bone Marrow Transplant; 2005 Oct; 36(7):631-7. PubMed ID: 16062176
    [Abstract] [Full Text] [Related]

  • 28. Parenteral glutamine protects hepatic function during bone marrow transplantation.
    Brown SA, Goringe A, Fegan C, Davies SV, Giddings J, Whittaker JA, Burnett AK, Poynton CH.
    Bone Marrow Transplant; 1998 Aug; 22(3):281-4. PubMed ID: 9720743
    [Abstract] [Full Text] [Related]

  • 29. [Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation].
    Salat C, Holler E, Reinhardt B, Kolb HJ, Pihusch R, Neumeister P, Hiller E.
    Med Klin (Munich); 1994 May 15; 89(5):245-7. PubMed ID: 8052177
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Humoral coagulation and early complications after allogeneic bone marrow transplantation.
    Nürnberger W, Kruck H, Mauz-Körholz C, Burdach S, Göbel U.
    Klin Padiatr; 1997 May 15; 209(4):209-15. PubMed ID: 9293452
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin.
    Simon M, Hahn T, Ford LA, Anderson B, Swinnich D, Baer MR, Bambach B, Bernstein SH, Bernstein ZP, Czuczman MS, Slack JL, Wetzler M, Herzig G, Schriber J, McCarthy PL.
    Bone Marrow Transplant; 2001 Mar 15; 27(6):627-33. PubMed ID: 11319593
    [Abstract] [Full Text] [Related]

  • 35. Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation.
    Lee KH, Lee JH, Choi SJ, Kim S, Lee JS, Kim SH, Kim WK.
    Bone Marrow Transplant; 1999 Sep 15; 24(6):591-9. PubMed ID: 10490723
    [Abstract] [Full Text] [Related]

  • 36. Plasma protein C is a useful clinical marker for hepatic veno-occlusive disease (VOD) in stem cell transplantation.
    Iguchi A, Kobayashi R, Kaneda M, Kobayashi K.
    Pediatr Blood Cancer; 2010 Mar 15; 54(3):437-43. PubMed ID: 19911420
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.
    Azoulay D, Castaing D, Lemoine A, Hargreaves GM, Bismuth H.
    Bone Marrow Transplant; 2000 May 15; 25(9):987-92. PubMed ID: 10800068
    [Abstract] [Full Text] [Related]

  • 39. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    Probst K, Fijnheer R, Rothova A.
    Am J Ophthalmol; 2004 May 15; 137(5):850-7. PubMed ID: 15126149
    [Abstract] [Full Text] [Related]

  • 40. Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation.
    Morio S, Oh H, Hirasawa A, Aotsuka N, Nakamura H, Asai T, Yoshida S, Ito M.
    Bone Marrow Transplant; 1991 Aug 15; 8(2):147-9. PubMed ID: 1933057
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.